Literature DB >> 33497469

Skin melanoma deaths within 1 or 3 years from diagnosis in Europe.

Lidia Sacchetto1,2,3, Stefano Rosso1, Harry Comber4, Christine Bouchardy5, Paolo Broganelli6, Jaume Galceran7, Monika Hackl8, Alexander Katalinic9, Marieke Louwman10, Trude E Robsahm11, Laufey Tryggvadottir12,13, Rosario Tumino14, Elizabeth Van Eycken15, Paul M Walsh4, Vesna Zadnik16, Roberto Zanetti1.   

Abstract

The steep increase in incidence of cutaneous malignant melanoma in white populations mainly applies to thin lesions with good survival suggesting overdiagnosis. Based on population-based cancer registries (CRs), we have investigated changes in aggressive melanoma, selecting only cases who died within 1 or 3 years after diagnosis in 11 European countries between 1995 and 2012. Trends in fatal cases were analysed by period of diagnosis, sex, tumour thickness, histologic subtype of the lesion, tumour site and CR with a multivariate generalised linear mixed effects model, where geographical area was considered as a random effect. We collected data on 123 360 invasive melanomas, with 5133 fatal cases at 1 year (4%) and 12 330 (10%) at 3 years. The number of fatal cases showed a 16% decrease at 1 year and 8% at 3 years between the first (1995-2000) and the last (2007-2012) period. The highest proportion of fatal cases was seen for men, older age (≥65 years), thick lesions (>1 mm), nodular melanoma, melanoma on the trunk and for poorly documented cases, lacking information about thickness and histologic subtype. The mixed-effects model showed a remarkable variability among European countries. The majority of registries showed a decreasing trend in fatal cases, but a few registries showed an opposite pattern. Trends in fatal melanoma cases, highlighting real changes in risk not related to overdiagnosis, showed a decrease in most European countries, with a few exceptions. Stronger efforts for early detection could lead to a more efficient treatment of melanoma in general.
© 2021 UICC.

Entities:  

Keywords:  Europe; lethality; melanoma; prognostic factors; trends

Year:  2021        PMID: 33497469     DOI: 10.1002/ijc.33479

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  2 in total

1.  Tetraspanin CD9 Expression Predicts Sentinel Node Status in Patients with Cutaneous Melanoma.

Authors:  Guendalina Lucarini; Elisa Molinelli; Caterina Licini; Giulio Rizzetto; Giulia Radi; Gaia Goteri; Monica Mattioli-Belmonte; Annamaria Offidani; Oriana Simonetti
Journal:  Int J Mol Sci       Date:  2022-04-26       Impact factor: 6.208

2.  Deciphering the Functional Role of RIPK4 in Melanoma.

Authors:  Ewelina Madej; Damian Ryszawy; Anna A Brożyna; Malgorzata Czyz; Jaroslaw Czyz; Agnieszka Wolnicka-Glubisz
Journal:  Int J Mol Sci       Date:  2021-10-25       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.